Matthew H. G

Jul 16, 2024 | academic.oup.com | Matthew H. G |Mahmoud Yousef

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult cancers to treat as it is often discovered at late stages.1-3 Prognosis is generally poor with a 1-year survival of less than 20% overall and a 5-year survival rate of less than 5% for metastatic disease.2 Current predictions suggest that the incidence of PDAC will become more prevalent, with associated mortality second only to lung cancer.2,4 Treatment for PDAC typically involves standard chemotherapy and potentially...